The Hypolipidemic Drugs Market is experiencing a significant shift as the global burden of cardiovascular diseases continues to rise. With hyperlipidemia—characterized by elevated levels of cholesterol and triglycerides—becoming a prevalent health concern across diverse demographics, the pharmaceutical industry is prioritizing the development of more effective, long-term...